Based on previous studies, it is also likely that, in hypoxic BC cells with augmented brain-metastatic capacity, HIF-1 has also programmed augmented cancer stem cell and immune evasive properties (37, 39, 89–92), which together are major determinants of the lethal cancer phenotype. This evidence concerns the gene HIF1A and cancer.